For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Anterogen Co. Ltd.

USPTO Granted Patents = 4

EPO Patents = 8

Forward Citations = 1

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Uma Sharan Singh (2 out of 4 patents)

Chung K Chu (2 out of 74 patents)

Kyung Sook Chung (1 out of 6 patents)

4. Sung-koo Lee (1 out of 3 patents)

5. Mi Hyung Kim (1 out of 1 patent)

6. Mihyung Kim (1 out of 1 patent)

7. Inok Kim (21 patents)

8. Junji Yamashita (1 patent)

9. Mi-Hyung Kim (0 patent)

10. In-Ok Kim (1 patent)

11. Sung-Koo Lee (0 patent)

4 patents: Sort by Forward Citations

1. 12454540 - Prodrugs of L-BHDU and methods of treating viral infections (2025-10-28),

2. 12350401 - Mesenchymal stem cells-hydrogel-biodegradable or mesenchymal stem cells-hydrogel-nondegradable support composition for alleviating or improving epidermolysis bullosa (2025-07-08),

3. 11945833 - Prodrugs of L-BHDU and methods of treating viral infections (2024-04-02),

4. 9874574 - Marker for detecting proliferation and treatment capacities of adipose-derived stem cell cultured in medium containing EGF or BFGF, and use thereof (2018-01-23),

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#680 in Seoul

#2,091 in South Korea

Seoul, South Korea

Anterogen Co. Ltd.

Forward Citations = 1

6 inventors:

Uma Sharan Singh (2 out of 4 patents)

Chung K Chu (2 out of 74 patents)

Kyung Sook Chung (1 out of 6 patents)

4. Sung-koo Lee (1 out of 3 patents)

5. Mi Hyung Kim (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…